Characteristic | No | % |
---|---|---|
Age (years) | ||
 ˂ 50 years | 29 | 74.4 |
 ≥ 50 years | 10 | 25.6 |
 Mean | 45.9 | |
 Standard deviation (SD) | 6.9 | |
ECOG PS | ||
 0, I | 11 | 18.3 |
 II | 28 | 81.7 |
Menopausal status | ||
 Pre/perimenopausal | 26 | 66.6 |
 postmenopausal | 13 | 33.3 |
Pathological type | ||
 IDC | 34 | 87.2 |
 ILC | 4 | 10.3 |
 Others | 1 | 2.6 |
Tumor grade | ||
 Grade I or II | 33 | 84.6 |
 Grade III | 6 | 15.4 |
Type of metastasis | ||
 De novo MBC | 8 | 20.5 |
 Recurrent MBC | 31 | 79.5 |
No of metastasized organ/s | ||
 One | 5 | 12.8 |
 Two or more | 34 | 87.2 |
Order of PLD line | ||
 3rd palliative | 13 | 33.3 |
 4th palliative or more | 26 | 66.6 |
Chemosensitivity | ||
 Chemosensitive | 14 | 35.9 |
 Chemoresistant | 25 | 64.1 |
Chemotherapy cycles | ||
 Total number | 222 | |
 Mode | 3 | |
 Range | 3–18 |